Verve Therapeutics Inc. (VERV)
6.18
-0.15 (-2.37%)
At close: Mar 03, 2025, 3:59 PM
6.15
-0.57%
After-hours: Mar 03, 2025, 04:47 PM EST
Verve Therapeutics Balance Sheet Statement
Year | FY24 | FY23 | FY22 | FY21 | FY20 | FY19 |
Cash & Equivalents | 172.56M | 206.18M | 115.41M | 64.33M | 8.99M | 2.99M |
Short-Term Investments | 351.72M | 417.77M | 439.4M | 296.11M | 63.12M | 15.8M |
Long-Term Investments | n/a | n/a | 4.82M | 5.24M | 463K | 235K |
Other Long-Term Assets | 7.92M | 6.94M | 585K | 2.7M | n/a | n/a |
Receivables | 3.25M | 5.9M | 1.01M | n/a | n/a | n/a |
Inventory | n/a | n/a | 1.00 | n/a | n/a | n/a |
Other Current Assets | 15.21M | 8.1M | 7.34M | 13.37M | 1.85M | 272K |
Total Current Assets | 542.75M | 637.95M | 563.16M | 367.13M | 73.97M | 19.05M |
Property-Plant & Equipment | 96.73M | 107.8M | 110.66M | 9.06M | 3.98M | 2.36M |
Goodwill & Intangibles | n/a | n/a | n/a | n/a | n/a | n/a |
Total Long-Term Assets | 104.64M | 114.74M | 116.06M | 17M | 4.45M | 2.59M |
Total Assets | 647.39M | 752.69M | 679.22M | 384.12M | 78.41M | 21.65M |
Account Payables | 4.52M | 6.64M | 2.42M | 7.08M | 36K | 2.41M |
Deferred Revenue | 3.6M | n/a | 20.01M | -12.99M | 90K | 31K |
Short-Term Debt | 10.44M | 10.19M | 23.81M | 3.91M | n/a | n/a |
Other Current Liabilities | 24.34M | 20.18M | 8.86M | 11.04M | 7.19M | 1.11M |
Total Current Liabilities | 42.91M | 37.01M | 35.09M | 22.02M | 7.32M | 3.55M |
Long-Term Debt | 59.54M | 64.72M | 70.01M | n/a | 125.16M | 35.05M |
Other Long-Term Liabilities | 51.54M | 2.91M | 3.17M | 4.75M | 9.72M | 2.46M |
Total Long-Term Liabilities | 111.08M | 116.18M | 93.2M | 4.75M | 135.01M | 37.65M |
Total Liabilities | 153.99M | 153.19M | 128.29M | 26.77M | 142.32M | 41.2M |
Total Debt | 69.98M | 74.91M | 81.92M | 1.96M | 125.16M | 35.05M |
Common Stock | 89K | 82K | 62K | 49K | 3K | 2K |
Retained Earnings | -743.01M | -544.3M | -344.24M | -186.85M | -66.54M | -20.83M |
Comprehensive Income | 428K | 272K | -694K | -228K | 8K | 9K |
Shareholders Equity | 493.4M | 599.5M | 550.93M | 357.35M | -63.91M | -19.55M |
Total Investments | 351.72M | 417.77M | 439.4M | 296.11M | 63.12M | 15.8M |